ArticleMolecular therapy : the journal of the American Society of Gene Therapy2014

SNS01-T modulation of eIF5A inhibits B-cell cancer progression and synergizes with bortezomib and lenalidomide.

Sarah M Francis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.